Delivery Order SPE2DR25D2014-SPE2DR26FA1V0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for AVEED 750 mg/3 mL vials with a ceiling value of $2,030.72. This is a firm fixed price delivery order with no set-aside designation, reflecting open competition for the pharmaceutical supply. The contract is set to be completed by December 31, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $14,452.05 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $30,460.80 for AVEED 750 mg/3 mL vials on November 17, 2025, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader relationship with the...
- The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $10,153.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for AVEED 750 mg/3 mL vials. This delivery order, with an ultimate completion date of January 14, 2026, represents a pediatric-focused pharmaceutical supply requirement fulfilled through the vendor's existing contract vehicle. The award was made on a competitive, non-set-aside basis to AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $5,780.82 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on September 23, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The contractor's place of performance is located in Conshohocken, Pennsylvania, the company's headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $73,105.92 to AmerisourceBergen Drug Corp for the supply of AVEED 750 mg/3 mL vials on November 6, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, featuring a completion date of December 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of AVEED 750 mg/3 mL vials. The order carries a ceiling value of $34,684.92 and is structured as a firm fixed-price delivery order with an ultimate completion date of June 23, 2025. This is a non-set-aside contract awarded through competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the medication AVEED 750 MG/3 ML VIAL 3ML, and has a ceiling value of $31,216.80. The award has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both companies are for-profit...
- The Defense Logistics Agency has awarded a $4,061.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for AVEED 750 MG/3 ML vials, a testosterone replacement therapy product, with an ultimate completion date of January 12, 2026. This is a non-set-aside, competitively awarded contract that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA1V0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,153.60 to AmerisourceBergen Drug Corp for the supply of AVEED 750 mg/3 ml vials on January 8, 2026, with completion targeted for January 30, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The current delivery order for AVEED represents a routine pharmaceutical supply fulfillment under this expansive contract vehicle that supports Defense Health Agency and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 1/7/26 |